´ëÇѼ¼Æ÷º´¸®ÇÐȸ
 
¹ßÀü±â±Ý   LOGIN   JOIN   SITEMAP   CONTACT   ENGLISH    ¤Ó   
> ¼Ò½ÄÁö > ÇÐȸÇà»ç¼Ò½Ä
ÇÐȸÇà»ç¼Ò½Ä
2025³â Á¦37Â÷ °¡À»Çмú´ëȸ

°¡À»Çмú´ëȸ´Â 2024³â 9¿ù 26ÀÏ(±Ý)°ú 27ÀÏ(Åä)¿¡ °ÉÃÄ ¼Ò³ëį ¿©¼ö ±×·£µåº¼·ë¿¡¼­ ÁøÇàµÇ¾ú½À´Ï´Ù. 

¸ðµÎ 314 ¸í(Àü¹®ÀÇ 153 ¸í, Àü°øÀÇ 34 ¸í, ¼¼Æ÷º´¸®»ç 122¸í, µ¿¹Ý°¡Á· 5¸í)ÀÌ µî·ÏÇÏ¿´½À´Ï´Ù.


Ư°­ ¹× ½ÉÆ÷Áö¿ò ³»¿ëÀº ´ÙÀ½°ú °°½À´Ï´Ù.

1) Ư°­ I

Pancreaticobiliary tract cytology: Àå±âÅà (¼º±Õ°üÀÇ´ë)


2) ½ÉÆ÷Áö¾ö I: Pancreaticobiliary tract cytology

LBC in Pancreaticobiliary tract cytology: ±è¹éÈñ (°í·ÁÀÇ´ë)

Pancreas FNA cytology: ³ªÈñ¿µ (¼­¿ïÀÇ´ë)

Ancillary tests for pancreaticobiliary tract cytology: ³²ÁöÇØ (¿¬¼¼ÀÇ´ë)

Bile duct brush cytology: ÃÖÇýÁ¤ (¿ï»êÀÇ´ë) 


3) Ư°­ II: Digital cytology and AI landscape: Recent Update


4) ¼¼Æ÷ Áø´ÜÀ» À§ÇÑ º´¸® ±³À° ÇÁ·Î±×·¥

Infectious disease and miscellaneous benign lesions in GYN pathology: ³ë¼Û¹Ì (Â÷ÀǰúÇдë)


5) ½ÉÆ÷Áö¾ö II: ºÎÀΰú ¼¼Æ÷º´¸®

Endocervical glandular lesions: ½ÅÁØ¿µ (±¹¸³¾Ï¼¾ÅÍ)

Endometrial glandular lesions: ¹ÚÈñÁ¤ (¿¬¼¼ÀÇ´ë)


ÇÐȸ ÃÑȸ¿¡¼­´Â Çмú»ó ½Ã»óÀÌ ÀÖ¾ú½À´Ï´Ù. 

´ë»óÀº ÀÇÁ¤ºÎ¼º¸ðº´¿ø Á¤¿ä¼Á ȸ¿øÀÌ 

 ¨çImproved Diagnostic Accuracy of Thyroid Fine-Needle Aspiration Cytology with Artificial Intelligence Technology, Thyroid2024 34(6):723-734 (IF:6.7), 

 ¨èArtificial-Intelligence-Assisted Detection of Metastatic Colorectal Cancer Cells in Ascitic Fluid, Cancers2024 16(5):1064 (IF:4.4)

³í¹®À¸·Î ¼ö»óÇÏ¿´½À´Ï´Ù. 


¿ì¼ö»óÀº ºÐ´ç¼­¿ï´ëº´¿ø ³ªÈñ¿µ ȸ¿ø°ú ¼­¿ï´ëÇб³ º´¿øÀÇ À¯ÇѼ® ȸ¿øÀÌ ¼ö»óÇÏ¿´À¸¸ç ³í¹®Àº ´ÙÀ½°ú °°½À´Ï´Ù.


³ªÈñ¿µ ȸ¿ø; Fine needle aspiration cytology diagnoses of follicular thyroid carcinoma: results from a multicenter study in Asia, PTM2024; 58: 331-340, 


À¯ÇѼ® ȸ¿ø; 

¨çComparison of Breast Fine-Needle Aspiration Cytology and Tissue Sampling for High-Throughput Proteomic Analysis and Cancer Biomarker Detection, Pathobiology2024;91(5):359-369, 

¨èDiscrepancies in Hormone Receptor and HER2 Expression between Malignant Serous Effusions and Paired Tissues from Primary or Recurrent Breast Cancers, Pathobiology2024;91(3):169-179, 

¨éExpression of EGFR, PD-L1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high-grade serous tubo-ovarian carcinoma, Diagnostic Cytopathology2024 Feb;52(2):69-75.


ÇмúÀå·Á»ó(JPTM¼¼Æ÷³í¹® ÃÖ´Ù°ÔÀç»ó)Àº ´ë»óÀÚ°¡ ¾ø¾ú½À´Ï´Ù.


Æ÷½ºÅÍ»ó ½Ã»ó¿¡¼­ ÃÖ¿ì¼ö Æ÷½ºÅÍ»óÀº ÀÌÀ¯Áø (°¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø), ¿ì¼öÆ÷½ºÅÍ»óÀº ¿À½ÂÁÖ (¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø), ¹®Áöȯ ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø), Á¤¿ä¼Á (°¡Å縯´ëÇб³ ÀÇÁ¤ºÎ¼º¸ðº´¿ø) Áõ·Ê ¿ì¼öÃÊ·Ï»óÀº Á¤¿¹½½ (°¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø) ȸ¿øÀÌ ¼ö»óÇÏ¿´½À´Ï´Ù.


27ÀÏ(Åä)¿¡´Â ÇÑÀÏÇмú´ëȸ(The 22nd Korea-Japan Joint Meeting for Diagnostic Cytopathology)°¡ °³ÃֵǾú½À´Ï´Ù.

ÀϺ»Ãø Âü¼®ÀÚ´Â 21¸í (Àü¹®ÀÇ 13¸í, ¼¼Æ÷º´¸®»ç 8¸í)À̾ú½À´Ï´Ù.


Plenary lecture ÁÖÁ¦´Â ´ÙÀ½°ú °°¾Ò½À´Ï´Ù.

Implementation and Evaluation of the New WHO Reporting System for Lung Cytopathology

- Prof. Yuko Minami (National Hospital Organization Ibarakihigashi National Hospital)

Diagnostic & Prognostic Biomarkers in Cytology: Multiorgan Perspectives

- Prof. Han Suk Ryu (Seoul National Univ. Hospital)


202537.jpg


(04195) ¼­¿ï½Ã ¸¶Æ÷±¸ ¸¸¸®Àç·Î 14, 1508È£ (°ø´öµ¿, Çѱ¹»çȸº¹Áöȸ°ü ¸£³×»ó½ºÅ¸¿ö)
l »ç¾÷ÀÚµî·Ï¹øÈ£:209-82-62797   l   ´ëÇ¥: ÃÖÀ±Á¤   l   e-mail: cytopathology@hanmail.net   l   tel : 02-593-6943   l   fax: 02-593-6944  
l   °³ÀÎÁ¤º¸Ã³¸®¹æÄ§   l   À̸ÞÀϹ«´Ü¼öÁý°ÅºÎ   l   Copyright (c) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ ALL RIGHT RESERVED.